Clinical Trial Update: Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated a topical gel containing baclofen, amitriptyline hydrochloride, and ketamine for chemotherapy-induced peripheral neuropathy in cancer …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Chemotherapy-induced Peripheral Neuropathy

Drugs mentioned

• Baclofen-Amitriptyline Hydrochloride-Ketamine Gel

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Chronic Myeloproliferative Disorders, Leukemia | Phase 3 | Status: COMPLETED | Results posted: 2017-08-24